171 related articles for article (PubMed ID: 36459028)
1. Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms.
Yasin EB; Alserihi R; Alkhatabi H; Qutob HMH; Qahwaji R; Kattan SW; Gholam KA; Hussein E; Barefah AS; Alghuthami ME; Abuzenadah A
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8451-8458. PubMed ID: 36459028
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.
Fourouclas N; Li J; Gilby DC; Campbell PJ; Beer PA; Boyd EM; Goodeve AC; Bareford D; Harrison CN; Reilly JT; Green AR; Bench AJ
Haematologica; 2008 Nov; 93(11):1635-44. PubMed ID: 18815196
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
5. Methylation of SOCS3 in Myeloproliferative Neoplasms and Secondary Erythrocytosis/Thrombocythemia.
Torun D; Nevruz O; Akyol M; Kozan S; Bahçe M; Güran S; Beyan C
Turk J Haematol; 2013 Mar; 30(1):13-8. PubMed ID: 24385747
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Methylation of Suppressor of Cytokine Signaling 1 (SOCS1) Gene as a Biomarker for Early Prediction and Diagnosis of Bladder Cancer.
Guan H; Li X; Lu J; Meng L; Guo Y; Dong J; Rong S; Zhao F; Shen H
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390384
[TBL] [Abstract][Full Text] [Related]
7. JAK2 inhibitors in the treatment of myeloproliferative neoplasms.
Tibes R; Bogenberger JM; Geyer HL; Mesa RA
Expert Opin Investig Drugs; 2012 Dec; 21(12):1755-74. PubMed ID: 22991927
[TBL] [Abstract][Full Text] [Related]
8. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
Zhang MY; Fung TK; Chen FY; Chim CS
J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases.
Teofili L; Martini M; Cenci T; Guidi F; Torti L; Giona F; Foà R; Leone G; Larocca LM
Int J Cancer; 2008 Oct; 123(7):1586-92. PubMed ID: 18623127
[TBL] [Abstract][Full Text] [Related]
11. One gene to rule them all - clinical perspectives of a potent suppressor of cytokine signaling - SOCS1.
Körholz J; Chen LS; Strauss T; Schuetz C; Dalpke AH
Front Immunol; 2024; 15():1385190. PubMed ID: 38711523
[TBL] [Abstract][Full Text] [Related]
12. [Effect of SOCS1 Gene on Growth Inhibition of Acute Myeloid Leukemia Cells Mediated by JAK2/STAT Signaling Pathway].
Zhang XH; Luo JM; Yang L; Liu XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1496-1503. PubMed ID: 33067944
[TBL] [Abstract][Full Text] [Related]
13. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
14. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
15. Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation.
Cooper JC; Shi M; Chueh FY; Venkitachalam S; Yu CL
Int J Oncol; 2010 May; 36(5):1201-8. PubMed ID: 20372794
[TBL] [Abstract][Full Text] [Related]
16. [Study of hypermethylation of SOCS gene in typical myeloproliferative disease].
Qin W; Li LL; Lu HN; Huang BB; Xiu B; Bo LJ; Gao QM; Zhang WJ; Fu JF
Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):772-6. PubMed ID: 22339915
[TBL] [Abstract][Full Text] [Related]
17. Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells.
Calabresi L; Balliu M; Bartalucci N
Methods Cell Biol; 2022; 171():81-109. PubMed ID: 35953207
[TBL] [Abstract][Full Text] [Related]
18. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
Čokić VP; Mitrović-Ajtić O; Beleslin-Čokić BB; Marković D; Buač M; Diklić M; Kraguljac-Kurtović N; Damjanović S; Milenković P; Gotić M; Raj PK
Mediators Inflamm; 2015; 2015():453020. PubMed ID: 26491227
[TBL] [Abstract][Full Text] [Related]
20. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
